Capital Fund Management S.A. Neurocrine Biosciences Inc Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 111,572 shares of NBIX stock, worth $13.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

111,572

Previous 56,951 95.91%

Holding current value

$13.8 Million

Previous $7.84 Million 63.84%

% of portfolio

0.04%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $6.26 Million - $8.37 Million	54,621 Added 95.91%	111,572 $12.8 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $7.45 Million - $8.15 Million	56,951 New	56,951 $7.84 Million
Q2 2021 Aug 12, 2021	SELL	$89.43 - $102.27 $5.39 Million - $6.16 Million	-60,266 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $3.54 Million - $4.82 Million	40,409 Added 203.5%	60,266 $5.86 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $244,217 - $304,407	-2,810 Reduced 12.4%	19,857 $1.9 Million
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $320,116 - $449,914	3,329 Added 17.21%	22,667 $2.18 Million
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $366,312 - $561,199	-4,305 Reduced 18.21%	19,338 $2.36 Million
Q1 2020 May 13, 2020	BUY	$75.11 - $113.76 $1.78 Million - $2.69 Million	23,643 New	23,643 $2.05 Million
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $581,040 - $703,598	-6,932 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $260,930 - $329,667	3,612 Added 108.8%	6,932 $585,000
Q1 2019 May 13, 2019	SELL	$69.31 - $91.53 $1.5 Million - $1.99 Million	-21,712 Reduced 86.74%	3,320 $292,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $938,170 - $1.71 Million	13,732 Added 121.52%	25,032 $1.79 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $1.12 Million - $1.42 Million	11,300 New	11,300 $1.39 Million

Others Institutions Holding NBIX

# of Institutions

624

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Neurocrine Biosciences Inc Transaction History